Starting on:
Mar 18, 2026
Ending on:
Mar 18, 2026
Moderator(s):
Venue:
KMA Centre
Max Credits:
3 Points
Provider:
KMA National Executive Council
Claim Points
Mar 18, 2026
Ending on:
Mar 18, 2026
Moderator(s):
KMA Centre
Max Credits:
3 Points
Provider:
KMA National Executive Council
Claim Points
Urate-Lowering Therapy in Gout: Optimizing Allopurinol (Zyloric) in Treat-to-Target Care
Starting on:
Mar 18, 2026
Mar 18, 2026
Ending on:
Mar 18, 2026
Mar 18, 2026
Venue:
KMA Centre
KMA Centre
Description
Urate-Lowering Therapy in Gout: Optimizing Allopurinol (Zyloric) in Treat-to-Target Care
Objectives
Practical insights into the use of urate-lowering therapy, with a focus on optimizing Allopurinol as part of a treat-to-target strategy for gout management.